Here’s what you’ll learn when you read this article: GLP‑1 and dual agonist drugs like tirzepatide have shown the ability to slow tumor growth in obesity‑linked cancers, especially in preclinical models. Early human…
Jessica DeBenedetto, a 43-year-old woman battling prediabetes since her 20s, recently started using compounded tirzepatide, a less expensive, generic alternative to Eli Lilly’s Zepbound. For her, the drug felt like a life-changer, especially…